Know Cancer

or
forgot password

Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract


Phase 2/Phase 3
18 Years
N/A
Not Enrolling
Both
Kidney Stone, Unexplained Haematuria, Benignant Tumour Mass in the Upper Urinary Tract

Thank you

Trial Information

Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract


Inclusion Criteria:



- Indication for ureterorenoscopy

- Age> 18 years

- Normal blood pressure

Exclusion Criteria:

- Malignant disease in the upper urinary tract

- Heart disease

- Allergy to Isoproterenol

- Use of α-blocking or β-blocking medicine

- Use of Calcium-antagonists

- Use of NSAIDs the last 48 hours

- Present stone or JJ-stent in the ureter

- Neurologic disease in the bladder

- Pregnancy

- Nursing mothers

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

pelvic pressure

Principal Investigator

Palle JS Osther, PhD, MD

Investigator Role:

Study Director

Investigator Affiliation:

Dp. of Urology, Fredericia & Kolding Hospitals, Fredericia, denmark

Authority:

Denmark: Danish Medicines Agency

Study ID:

HJ2

NCT ID:

NCT00428428

Start Date:

February 2007

Completion Date:

November 2007

Related Keywords:

  • Kidney Stone
  • Unexplained Haematuria
  • Benignant Tumour Mass in the Upper Urinary Tract
  • kidney stone
  • ureteroscopy
  • Hematuria
  • Kidney Calculi
  • Nephrolithiasis

Name

Location